Advanced search
Publication Cover
Drug Development and Industrial Pharmacy Volume 37, 2011 - Issue 12
Submit an article Journal homepage
464
Views
13
CrossRef citations to date
0
Altmetric
Research Article

A strategy for reducing particulate contamination on opening glass ampoules and development of evaluation methods for its application

Kyeong-Ryoon LeeDepartment of Pharmaceutics, College of Pharmacy, Seoul National University, Gwanak-gu, Seoul, South Korea
,
Yoon-Jee ChaeDepartment of Pharmaceutics, College of Pharmacy, Seoul National University, Gwanak-gu, Seoul, South Korea
,
Sung-Eel ChoKT&G Central Research Institute, Yuseong-gu, Daejeon, South Korea
&
Suk-Jae ChungDepartment of Pharmaceutics, College of Pharmacy, Seoul National University, Gwanak-gu, Seoul, South KoreaCorrespondence[email protected]
Pages 1394-1401 | Received 18 Jan 2011, Accepted 05 Apr 2011, Published online: 27 Jun 2011

References

  • Ernerot L, Dahlinder LE. (1969). The contamination of ampoules in connection with opening. Acta Pharm Suec, 6:401–406.
  • Turco S, Davis NM. (1972). Glass particles in intravenous injections. N Engl J Med, 287:1204–1205.
  • Katz H, Borden H, Hirscher D. (1973). Glass-particle contamination of color-break ampules. Anesthesiology, 39:354.
  • Dorris GG, Bivins BA, Rapp RP, Weiss DL, DeLuca PP, Ravin MB. (1977). Inflammatory potential of foreign particulates in parenteral drugs. Anesth Analg, 56:422–428.
  • Carbone-Traber KB, Shanks CA. (1986). Glass particle contamination in single-dose ampules. Anesth Analg, 65:1361–1363.
  • Gillies IR, Thiel WJ, Oppenheim RC. (1986). Particulate contamination of Australian ampoules. J Pharm Pharmacol, 38:87–92.
  • Sabon RL Jr, Cheng EY, Stommel KA, Hennen CR. (1989). Glass particle contamination: Influence of aspiration methods and ampule types. Anesthesiology, 70:859–862.
  • Turco SJ, Davis NM. (1971). Detrimental effects of particulate matter on the pulmonary circulation. JAMA, 217:81–82.
  • DeLuca PP, Rapp RP, Bivins B, McKean HE, Griffen WO. (1975). Filtration and infusion phlebitis: A double-blind prospective clinical study. Am J Hosp Pharm, 32:1001–1007.
  • Schroeder HG, DeLuca PP. (1976). Particulate matter assessment of a clinical investigation on filtration and infusion phlebitis. Am J Hosp Pharm, 33:543–546.
  • Stehbens WE, Florey HW. (1960). The behavior of intravenously injected particles observed in chambers in rabbits’ ears. Q J Exp Physiol Cogn Med Sci, 45:252–264.
  • Garvan JM, Gunner BW. (1964). The harmful effects of particles in intravenous fluids. Med J Aust, 2:1–6.
  • Michaels L, Poole RW. (1970). Injection granuloma of the buttock. Can Med Assoc J, 102:626–628.
  • Bélanger-Annable M.C. (1985). Long-acting neuroleptics: Technique for intramuscular injection. Can Nurse, 81:41–43.
  • Shaw NJ, Lyall EG. (1985). Hazards of glass ampoules. Br Med J (Clin Res Ed), 291:1390.
  • Hay J. (1995). Complications at site of injection of depot neuroleptics. BMJ, 311:421.
  • Cockshott WP, Thompson GT, Howlett LJ, Seeley ET. (1982). Intramuscular or intralipomatous injections? N Engl J Med, 307:356–358.
  • Beyea SC, Nicoll LH. (1995). Administration of medications via the intramuscular route: an integrative review of the literature and research-based protocol for the procedure. Appl Nurs Res, 8:23–33.
  • Day J, Henderson B, Butterworth T. (1995). Shaping up the depot. Nurs Times, 91:51–54.
  • Beyea SC, Nicoll LH. (1996). Back to basics. Administering i.m. injections the right way. Am J Nurs, 96:34–35.
  • Furgang FA. (1974). Letter: Glass particles in ampules. Anesthesiology, 41:525.
  • Katz H, Borden H, Hirscher D. (1974). Glass particle contamination of solutions. JAMA-J Am Med Assoc, 229:1169.
  • Zabir AF, Choy CY, Rushdan R. (2008). Glass particle contamination of parenteral preparations of intravenous drugs in anaesthetic practice. Southern African Journal of Anaesthesia and Analgesia, 14:17–19.
  • Yorioka K, Oie S, Kamiya A. (2009). Comparison of particulate contamination in glass and plastic ampoules of glycyrrhizin injections after ampoule cutting. J Food Drug Anal, 17:225–228.
  • Oie S, Kamiya A. (2005). Particulate and microbial contamination in in-use admixed parenteral nutrition solutions. Biol Pharm Bull, 28:2268–2270.
  • Preston ST, Hegadoren K. (2004). Glass contamination in parenterally administered medication. J Adv Nurs, 48:266–270.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.